Skip to main content
padlock icon - secure page this page is secure

The Clinical Pathway for Hypertensive Patient of Local Health Unit, Hospitals and General Practitioners, the Milan Experience

Buy Article:

$63.00 + tax (Refund Policy)

The Clinical Pathway (in its complete definition Diagnostic, Clinical and Therapeutic Pathway - Percorso Diagnostico Terapeutico Assistenziale - PDTA), originally started to deal with the newly diagnosed hypertensive patient, developed also recommendations for the first-line drugs in case of specific indications/contraindications and organ damages. It has been developed by a working group of specialists in cardiology, nephrology, internal medicine (faculty included) designated by their hospitals (both public and private accredited), including all the main city hospitals, by general practitioners designated by the Medical Unions SNAMI, FIMMG, SMI and SiMI and by public health doctors belonging to the Local Health Unit of Milan, who have coordinated the proceedings and have guaranteed that possible conflicts of interest of single participants could not interfere with the PDTA, anyway approved by all in July 2009. The PDTA deals with the measuring and self- home-monitoring of blood pressure (BP) and the diagnosis of hypertension; it revises, sometimes “dries up” and rationalizes the recommendations for diagnostic tests and specialist evaluations; it develops prevention and non-pharmacological treatments, proposing also tools for patients and for prescribing correct nutrition and physical activity and a structured program for BP monitoring; but the main feature is the innovations brought in the proposed drug treatment in comparison with the current clinical practice.





No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: ACEi; ARB; BB; BPLTTC; CA; CHARM; Cardiovascular risk; Diuretics; ELITE II; IDNT; LIFE; Labetalol (BB); MOSES; Metildopa; NEDD4L; OPTIMAAL; RCT Syst-Eur; RCTs; RENAAL; SCOPE; Sick Sinus Syndrome or AV; Tachiarrhytmias; VAL-HEFT; VALIANT; WNK1; alpha-ADDUCIN; anti hypertensive therapy; blocker (risk of orthostatic hypotension); clinical trial; hydrochlorothiazide; indapamide; thiazidetype (TT)

Document Type: Research Article

Publication date: 01 January 2011

More about this publication?
  • Reviews on Recent Clinical Trials publishes frontier reviews on recent clinical trials of major importance. The journal's aim is to publish the highest quality review articles in the field. Topics covered include: important Phase I - IV clinical trial studies, clinical investigations at all stages of development and therapeutics.

    The journal is essential reading for all researchers and clinicians involved in drug therapy and clinical trials.
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more